<DOC>
	<DOCNO>NCT02137616</DOCNO>
	<brief_summary>This study assess safety effect atypical antipsychotic subject psychosis syndrome psychosis risk syndrome .</brief_summary>
	<brief_title>Antipsychotic Treat Psychosis Syndrome</brief_title>
	<detailed_description>The investigator investigate whether administration atypical antipsychotic could alleviate prodromal symptom well tolerated subject psychosis syndrome psychosis risk syndrome .</detailed_description>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>helpseeking young individual outpatient service age 1630 year fit one follow Criteria : Psychosisrisk Syndromes ( COPSSIPS ) Psychotic Syndrome ( POPSSIPS ) DSMIV diagnosis schizophreniform disorder previous diagnosis psychotic disorder bipolar disorder accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ; symptom fully account Axis 1 disorder sequela drug/alcohol use ; neurological disorder organic disorder affect central nervous system , substancerelated disorder mental retardation define DSMIV criterion ; history treatment antipsychotic antidepression , mood stabilizer electroconvulsive therapy ; diagnose serious unstable medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>psychosis</keyword>
	<keyword>syndrome</keyword>
	<keyword>risk</keyword>
	<keyword>antipsychotic</keyword>
</DOC>